Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implications

Ovidiu Vornicu; Emily Perriens; Sydney Blackman; Elina Smoos; Christophe Al Sammour; Ilann Oueslati; Alexis Philippot; David Vidal Bankier; Charbel Haddad; Maha Bendoumou; Tom François; Isabelle Michaux; Anne-Sophie Dincq; Patrick Evrard; Pierre Bulpa; Patrick M Honore

doi:10.21037/atm-23-1719

Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implications

Ann Transl Med. 2023 Oct 25;11(11):395. doi: 10.21037/atm-23-1719. Epub 2023 Aug 18.

Authors

Ovidiu Vornicu^{1

2}, Emily Perriens³, Sydney Blackman³, Elina Smoos⁴, Christophe Al Sammour⁴, Ilann Oueslati⁴, Alexis Philippot⁴, David Vidal Bankier⁴, Charbel Haddad⁴, Maha Bendoumou⁴, Tom François⁴, Isabelle Michaux¹, Anne-Sophie Dincq^{1

2}, Patrick Evrard¹, Pierre Bulpa¹, Patrick M Honore¹

Affiliations

¹ ICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
² ICU and Anesthesiology Departments, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
³ ULB University Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
⁴ ULB University, Brussels, Belgium.

No abstract available

Keywords: 28 days mortality; Severe community-acquired pneumonia (severe CAP); hydrocortisone; implications for clinicians; septic shock excluded.

Publication types

Editorial
Comment